All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 26, 2021
Home » Authors » Sharon Kingman

Sharon Kingman

Articles

ARTICLES

Study suggests T helper cells will be harnessed for immunotherapy

Dec. 31, 2014
By Sharon Kingman
No Comments
LONDON – T helper cells, which help to coordinate the immune response, do recognize mutations found in cancer cells, researchers have found. The discovery suggests that it may one day be possible to use T helper cells in cancer immunotherapy, by stimulating them to recognize specific tumors.
Read More

Molecule found in lung cancer cells could be new target

Dec. 24, 2014
By Sharon Kingman
No Comments
LONDON – Scientists reported that they have found an ideal drug target that could lead to a treatment for lung cancer. The study, by an international team of researchers, identified a molecule that is found in lung cancer cells but not in normal lung tissue.
Read More

Study points to daily injection for diabetes and obesity combined

Dec. 10, 2014
By Sharon Kingman
No Comments
LONDON – "Superdrugs" – single peptides containing several hormonal activities – could be available to treat diabetes and obesity within a few years, scientists suggest. One of those composite molecules has already shown promising results in rodent models of diabetes and obesity and could provide a medical alternative to gastric bypass surgery, the researchers said.
Read More

Gene therapy cures mice of cardiomyopathy

Dec. 5, 2014
By Sharon Kingman
No Comments
LONDON – Gene therapy for babies born with a rare, but severe type of inherited heart disease could become a realistic option in the future, scientists suggest, following successful prevention of disease in a related mouse model
Read More

Spaghetti junction controls molecular traffic to the nucleus

Nov. 26, 2014
By Sharon Kingman
No Comments
LONDON – One of the latest techniques for understanding the structure of the pores that control what can enter and leave cell nuclei involves poking and feeling the molecules inside the pores using a very, very tiny spike of silicon.
Read More

Influenza drug targets become crystal clear

Nov. 21, 2014
By Sharon Kingman
No Comments
LONDON – The knowledge of the exact structure of the enzyme that the influenza virus uses to make new influenza viruses will give a huge boost to the search for drugs to treat that infection, scientists predict.
Read More

SPHINX solves the riddle of how to block angiogenesis

Nov. 13, 2014
By Sharon Kingman
No Comments
LONDON – New drugs to treat cancer, which work by stopping the formation of new blood vessels in the tumor, are in the pipeline and could enter clinical trials within a few years.
Read More

Study reveals potential pathway for diabetes and obesity treatment

Nov. 5, 2014
By Sharon Kingman
No Comments
LONDON – Damping down a type of low-grade inflammation that occurs in adipose tissue – particularly in those who are obese – could be a way to control type 2 diabetes and obesity in the future, scientists said.
Read More

Huge spread of genes contributes to autism, study finds

Oct. 30, 2014
By Sharon Kingman
No Comments
LONDON – The discovery of more than 30 genes containing new mutations that are highly likely to play a role in the development of autism spectrum disorder (ASD) will provide new insights into the causes of these conditions.
Read More

New target could lead to drugs to stimulate bone formation

Oct. 22, 2014
By Sharon Kingman
No Comments
LONDON – New drugs that will help boost the density of bone in conditions such as osteoporosis could be developed as a result of a new understanding of how bone cells interact with each other. Researchers working in Germany have established how the hormone calcitonin regulates bone remodeling via a receptor found on bone cells.
Read More
View All Articles by Sharon Kingman

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 25.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing